Equities

PetVivo Holdings Inc

PETV:PKC

PetVivo Holdings Inc

Actions
  • Price (USD)0.46
  • Today's Change-0.012 / -2.54%
  • Shares traded10.09k
  • 1 Year change-77.34%
  • Beta2.4306
Data delayed at least 15 minutes, as of Jul 05 2024 20:12 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

PetVivo Holdings, Inc. is a biomedical device company focused on the manufacturing, commercialization and licensing of medical devices and therapeutics for companion animals. The Company has developed a pipeline of products for the medical treatment of animals and people, with a portfolio of 21 patents that protect the Company’s biomaterials, products, production processes and methods of use. Spryng with OsteoCushion Technology, its flagship product, is a veterinarian-administered, intra-articular injectable designed for the management of lameness and other joint related afflictions, including osteoarthritis, in cats, dogs and horses. It also has a pipeline that includes several therapeutic devices for both veterinary and human clinical applications. The Company manufactures its products in an ISO 7 certified clean room manufacturing facility in Minneapolis using its patented and scalable self-assembly production process. The Company may establish strategic out-licensing partnerships.

  • Revenue in USD (TTM)1.05m
  • Net income in USD-10.63m
  • Incorporated2009
  • Employees25.00
  • Location
    PetVivo Holdings Inc5251 Edina Industrial BlvdEDINA 55439United StatesUSA
  • Phone+1 (952) 217-4952
  • Fax+1 (775) 884-9383
  • Websitehttps://petvivo.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
ALR Technologies Inc9.49k-8.00m6.10m6.00------642.83-0.0147-0.01470.00002-0.04760.0358----1,581.67-3,015.28-12,861.64----62.49---84,283.24-406,011.30---0.8626---------42.72------
Caduceus Software Systems Corp0.00-117.60k6.21m0.00---------0.0004-0.00040.00-0.00040.00-------402.19-11,090.31---------------76.88---------20,519.89------
Aethlon Medical, Inc.574.25k-12.26m6.26m15.00--0.1537--10.90-5.03-5.030.23622.930.0369----38,283.33-78.62-75.30-92.02-84.98-----2,133.17-1,783.78----0.00--95.2130.86-15.55--106.99--
Sigyn Therapeutics Inc0.00-3.56m6.43m5.00---------3.04-3.040.00-3.280.00----0.00-724.37-493.15-----------10,223.960.0199-1.92---------41.51------
PAVmed Inc3.02m-71.05m6.68m107.00------2.21-9.08-9.080.3874-7.760.0588--64.1728,186.92-147.38-154.56---1,152.82-126.09---2,505.37-8,764.890.5301-8.321.82--550.40--25.76--55.51--
Golden Valley Development Inc0.00-92.53k6.84m0.00---------11.17-11.170.00-0.02110.00-------7,710.83-------------3,073.27---3.96--------45.48------
Biomerica Inc5.41m-6.35m7.33m62.00--0.9393--1.36-0.3789-0.37890.32240.46420.58272.285.7487,180.80-68.45-43.55-83.73-50.3211.4115.75-117.46-55.863.37--0.00---71.71-0.8229-57.58---9.76--
Fuse Medical Inc18.40m3.63m7.38m31.002.78--2.000.40110.0360.0360.2307-0.00310.95930.70185.75593,671.9018.910.750448.451.3564.9554.9819.720.65520.3143-1.131.12---8.67-6.72295.1134.66----
Vivos Therapeutics Inc13.36m-15.64m7.42m114.00--10.79--0.5555-11.00-11.008.730.21310.9247--31.59117,219.30-108.24-89.72-243.30-149.7058.9070.20-117.06-113.15----0.00---13.8729.4843.04---8.48--
Neurometrix Inc5.27m-7.98m7.44m26.00--0.392--1.41-6.32-6.324.209.440.23811.2510.08202,700.40-36.07-23.24-38.94-27.2661.9759.17-151.51-48.8810.11--0.00---28.52-18.18-47.84--5.03--
Precipio Inc15.81m-4.90m7.50m51.00--0.5713--0.4742-3.73-3.7311.608.930.877317.8517.93310,039.20-27.20-44.98-34.82-58.6839.1428.80-31.00-118.070.6201-350.950.0278--61.4639.6252.04--5.37--
Guided Therapeutics Inc82.00k-3.23m8.01m4.00------97.72-0.0623-0.06230.0016-0.07210.03740.090411.7120,500.00-137.80-136.13----32.9329.39-3,685.37-3,666.670.1138-11.13----653.8511.4524.40------
PetVivo Holdings Inc1.05m-10.63m9.16m25.00--7.67--8.75-0.8694-0.86940.08420.060.33751.212.0441,841.60-343.12-209.90-715.73-504.6451.4120.27-1,016.55-2,297.210.6169-2,268.840.1392--693.46260.32-73.83--51.73--
Innovative Eyewear Inc1.39m-7.20m9.82m11.00--1.42--7.06-0.6074-0.60740.11740.29480.28031.8915.42126,457.30-145.15---168.75---8.82---517.88--3.68-6,764.710.00--74.67---17.28------
STRATA Skin Sciences Inc32.55m-11.36m10.83m99.00--1.15--0.3329-3.25-3.259.312.690.733.678.60328,737.40-25.49-11.48-35.77-16.5552.7161.28-34.91-17.700.8376-3.900.6151---7.752.24-95.17--23.29--
Autonomix Medical Inc0.00-15.43m12.06m5.00--1.58-----0.7614-0.76140.000.4048------0.00--------------------0.1161-------674.99------
Data as of Jul 05 2024. Currency figures normalised to PetVivo Holdings Inc's reporting currency: US Dollar USD

Institutional shareholders

2.83%Per cent of shares held by top holders
HolderShares% Held
Bard Associates, Inc.as of 31 Mar 2024418.80k2.46%
Regal Investment Advisors LLCas of 31 Mar 202419.00k0.11%
Asset Dedication LLCas of 31 Mar 202414.57k0.09%
Boothbay Fund Management LLCas of 31 Mar 202413.89k0.08%
Cetera Investment Advisers LLCas of 31 Mar 202410.00k0.06%
Tower Research Capital LLCas of 31 Mar 20245.32k0.03%
Bank of America, NA (Private Banking)as of 31 Mar 20241.00k0.01%
Delos Wealth Advisors LLCas of 31 Mar 20245.000.00%
Koshinski Asset Management, Inc.as of 31 Mar 20240.000.00%
HRT Financial LLCas of 31 Mar 20240.000.00%
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.